Ray Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer operated by the Rahimtoola Group, with an ISO-certified manufacturing facility at S.I.T.E.
Ray Pharma products in Pakistan
Ray Pharma has 58 medicine presentations registered in Pakistan under 39 brands, covering 32 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are Nixaray (Ciprofloxacin), Mikaray (Amikacin), Quezal (Quetiapine) and Rayaz (Azithromycin). 58 products have an official DRAP price on MedInfoBase. See all 39 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Ray Pharma (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- Rahimtoola House, 38-C Khayaban-e-Shahbaz, DHA Phase VI, Karachi, Pakistan
- Website
- raypharma.com.pk ↗
- Phone
- +92 21 35243301-06
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Oct 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Ray Pharma is priced against the market
48 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aclic | Zoledronic acid | 5 mg/100 mL | IV infusion | 100ml vial | 086784 | PKR 30,876.73 | PKR 308.77/mL | 🔒 Pharma Pro |
| Altis DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 1x8's | 076680 | PKR 563.04 | PKR 70.38/tablet | 🔒 Pharma Pro |
| Altis Plus | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 1x4's | 076681 | PKR 469.20 | PKR 117.30/tablet | 🔒 Pharma Pro |
| Crixan | Clarithromycin | 125 mg | Dry suspension | 60ml | 076588 | PKR 460.56 | PKR 7.68/mL | No comparator |
| Genticyn | Gentamicin | 40 mg | Injection | 3 x 1ml | 000500 | PKR 124.62 | PKR 41.54/mL | 🔒 Pharma Pro |
| Genticyn Eye/Ear Gentamycin Sulphate 0.003Source observed | — | — | — | 7.5ml | 000482Official source ↗ | No indexed price | — | — |
| Genticyn Gentamycin Sulphate | Gentamicin | 80 mg | Injection | 2 x 2ml | 000500 | PKR 118.66 | PKR 29.67/mL | 🔒 Pharma Pro |
| Genticyn HC | Gentamicin + Hydrocortisone | 0.3 % + 1 % | Eye/ear drops | 7.5ml | 004298 | PKR 63.02 | PKR 8.40/mL | No comparator |
| Genticyn Paediatric | Gentamicin | 20 mg/2 mL | Injection | 5 x 2ml | 010098 | PKR 130.29 | PKR 13.03/mL | 🔒 Pharma Pro |
| Locadent | Lidocaine + Adrenaline | 2% + 1:80,000 | Injection | 50"s Ampoules | 079959 | PKR 1,132.57 | — | No comparator |
| Mikaray | Amikacin | 100 mg/2 mL | Injection | 1s | 053313 | PKR 84.68 | PKR 84.68/vial/unit | 🔒 Pharma Pro |
| Mikaray | Amikacin | 250 mg/2 mL | Injection | 1s | 053314 | PKR 140.76 | PKR 140.76/vial/unit | 🔒 Pharma Pro |
| Mikaray | Amikacin | 500 mg/2 mL | Injection | 1s | 053315 | PKR 258.17 | PKR 258.17/vial/unit | 🔒 Pharma Pro |
| Neo-Mercazole | Carbimazole | 5 mg | Tablet | 100's | 000494 | PKR 300.75 | PKR 3.01/tablet | 🔒 Pharma Pro |
| Netidin | Netilmicin | 3 mg/mL | Ophthalmic drops | 5ml | 076594 | PKR 431.54 | PKR 86.31/mL | No comparator |
| Nicotrim Forte | Sulfamethoxazole + Trimethoprim | 800 mg + 160 mg | Tablet | 100s | 005334 | PKR 793.85 | PKR 7.94/tablet | 🔒 Pharma Pro |
| Nicotrim PeadiatricSource observed | Trimethoprim | 40 mg | Suspension | 120ml | 112760Official source ↗ | No indexed price | — | — |
| Nicotrim Peadiatric Suspension Trimethoprim +Sulphamethoxazole 40mg/200mgSource observed | — | — | — | 120ml | 112760Official source ↗ | No indexed price | — | — |
| Nixaray | Ciprofloxacin | 250 mg | Tablet | 10's | 112816 | PKR 268.50 | PKR 26.85/tablet | 🔒 Pharma Pro |
| Nixaray | Ciprofloxacin | 500 mg | Tablet | 60's | 112817 | PKR 2,390.58 | PKR 39.84/tablet | 🔒 Pharma Pro |
| Nixaray | Ciprofloxacin | 500 mg | Tablet | 10's | 112817 | PKR 415.68 | PKR 41.57/tablet | 🔒 Pharma Pro |
| Nixaray | Ciprofloxacin | 500 mg | Tablet | 100's | 112817 | PKR 3,984.30 | PKR 39.84/tablet | 🔒 Pharma Pro |
| Nixaray | Ciprofloxacin | 500 mg | Tablet | 14's | 112817 | PKR 580.76 | PKR 41.48/tablet | 🔒 Pharma Pro |
| Nixaray | Ciprofloxacin | 500 mg | Tablet | 50's | 112817 | PKR 1,991.40 | PKR 39.83/tablet | 🔒 Pharma Pro |
| Oculol | Dorzolamide + Timolol | 20 mg/mL + 5 mg/mL | Ophthalmic drops | 5 ml | 076591 | PKR 1,459.36 | PKR 291.87/mL | No comparator |
| Ozamine | Olanzapine | 5 mg | Tablet | 10's | 103208 | PKR 155.65 | PKR 15.57/tablet | 🔒 Pharma Pro |
| Prednocin 5ml Loteprednol Etabonate + TobbramycinSource observed | — | — | Ophthalmic drops | 5ml×1's | 110322Official source ↗ | No indexed price | — | — |
| Pruine | Aciclovir | 5 % | Ointment | 5gm | 090904 | PKR 157.46 | PKR 31.49/g | 🔒 Pharma Pro |
| Prurine | Aciclovir | 400 mg | Tablet | 35's | 112612 | PKR 1,582.19 | PKR 45.21/tablet | 🔒 Pharma Pro |
| Quezal | Quetiapine | 25 mg | Tablet | 3x 10's | 105350 | PKR 499.43 | PKR 16.65/tablet | 🔒 Pharma Pro |
| Quezal | Quetiapine | 25 mg | Tablet | 1x10's | 105350 | PKR 166.48 | PKR 16.65/tablet | 🔒 Pharma Pro |
| Quezal | Quetiapine | 25 mg | Tablet | 2x10's | 105350 | PKR 332.95 | PKR 16.65/tablet | 🔒 Pharma Pro |
| Rasimet 10+ Ezitimibe+ | Ezetimibe + Simvastatin | 10 mg + 10 mg | Tablet | 7's | 067221 | PKR 291.87 | PKR 41.70/tablet | 🔒 Pharma Pro |
| Rasimet 10+ Ezitimibe+ | Ezetimibe + Simvastatin | 10 mg + 20 mg | Tablet | 7's | 067222 | PKR 1,021.55 | PKR 145.94/tablet | No comparator |
| Rayart | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 2 x 8 | 058254 | PKR 660.90 | PKR 41.31/tablet | 🔒 Pharma Pro |
| Rayaz | Azithromycin | 250 mg | Capsule | 1 x 6 | 053292 | PKR 471.13 | PKR 78.52/capsule | 🔒 Pharma Pro |
| Rayaz | Azithromycin | 200 mg/5 mL | Dry suspension | 15 ml | 076589 | PKR 345.50 | PKR 23.03/mL | 🔒 Pharma Pro |
| Rayaz | Azithromycin | 500 mg | Tablet | 1 x 6 | 076682 | PKR 575.82 | PKR 95.97/tablet | 🔒 Pharma Pro |
| Raycan-H | Candesartan + Hydrochlorothiazide | 12.5 mg + 16 mg | Tablet | 28's | 067220 | PKR 1,359.64 | PKR 48.56/tablet | No comparator |
| Raydex T | Tobramycin + Dexamethasone | 3 mg/mL + 1 mg/mL | Ophthalmic drops | 5 ml | 074968 | PKR 244.59 | PKR 48.92/mL | No comparator |
| Raygil | Metronidazole | 200 mg | Tablet | 20 x 10 | 058251 | PKR 534.79 | PKR 2.67/tablet | 🔒 Pharma Pro |
| Raygil | Metronidazole | 400 mg | Tablet | 20 x 10 | 058252 | PKR 776.22 | PKR 3.88/tablet | 🔒 Pharma Pro |
| Raylox | Levofloxacin | 250 mg | Tablet | 1 x 10 | 053306 | PKR 516.33 | PKR 51.63/tablet | 🔒 Pharma Pro |
| Raylox | Levofloxacin | 500 mg | Tablet | 1 x 10 | 053307 | PKR 859.18 | PKR 85.92/tablet | 🔒 Pharma Pro |
| Raylox | Levofloxacin | 750 mg | Tablet | 1 x 10 | 076679 | PKR 472.96 | PKR 47.30/tablet | 🔒 Pharma Pro |
| Raymal | Artemether | 80 mg/mL | Injection | 1 x 6 | 053316 | PKR 1,028.55 | PKR 171.43/vial/unit | 🔒 Pharma Pro |
| Raymox | Moxifloxacin | 400 mg | Tablet | 1 x 5 | 053299 | PKR 690.98 | PKR 138.20/tablet | 🔒 Pharma Pro |
| Rayplat | Clopidogrel | 75 mg | Tablet | 1 x 10 | 053293 | PKR 293.15 | PKR 29.32/tablet | 🔒 Pharma Pro |
| Raypride-M 1+ | Glimepiride + Metformin | 500 mg + 1 mg | Tablet | 3 x 10's | 067218 | PKR 291.87 | PKR 9.73/tablet | No comparator |
| Raypride-M 2+ | Glimepiride + Metformin | 500 mg + 2 mg | Tablet | 3 x 10's | 067219 | PKR 474.29 | PKR 15.81/tablet | No comparator |
All 39 Ray Pharma brands in Pakistan
- Aclic Zoledronic acid · 5 mg/100 mL infusion
- Altis DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Altis Plus Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Crixan Clarithromycin · 125 mg suspension
- Genticyn Gentamicin · 40 mg injection
- Genticyn Gentamycin Sulphate Gentamicin · 80 mg injection
- Genticyn HC Gentamicin + Hydrocortisone · 0.3 % + 1 % drops
- Genticyn Paediatric Gentamicin · 20 mg/2 mL injection
- Locadent Lidocaine + Adrenaline · 2% + 1:80,000 injection
- Mikaray Amikacin · 100 mg/2 mL injection, 250 mg/2 mL injection, 500 mg/2 mL injection
- Neo-Mercazole Carbimazole · 5 mg tablet
- Netidin Netilmicin · 3 mg/mL drops
- Nicotrim Forte Sulfamethoxazole + Trimethoprim · 800 mg + 160 mg tablet
- Nixaray Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Oculol Dorzolamide + Timolol · 20 mg/mL + 5 mg/mL drops
- Ozamine Olanzapine · 5 mg tablet
- Pruine Aciclovir · 5 % ointment
- Prurine Aciclovir · 400 mg tablet
- Quezal Quetiapine · 25 mg tablet
- Rasimet 10+ Ezitimibe+ Ezetimibe + Simvastatin · 10 mg + 10 mg tablet, 10 mg + 20 mg tablet
- Rayart Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Rayaz Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
- Raycan-H Candesartan + Hydrochlorothiazide · 12.5 mg + 16 mg tablet
- Raydex T Tobramycin + Dexamethasone · 3 mg/mL + 1 mg/mL drops
- Raygil Metronidazole · 200 mg tablet, 400 mg tablet
- Raylox Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Raymal Artemether · 80 mg/mL injection
- Raymox Moxifloxacin · 400 mg tablet
- Rayplat Clopidogrel · 75 mg tablet
- Raypride-M 1+ Glimepiride + Metformin · 500 mg + 1 mg tablet
- Raypride-M 2+ Glimepiride + Metformin · 500 mg + 2 mg tablet
- Raytor Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Raytor Plus 10mg Amlodipine + Atorvastatin · 10 mg + 10 mg tablet
- Raytor Plus 5mg Amlodipine + Atorvastatin · 5 mg + 10 mg tablet
- Raytrax Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
- Rayzac Fluoxetine · 20 mg capsule
- Rayzolim Acetazolamide · 250 mg tablet
- Risperto Risperidone · 1 mg tablet, 2 mg tablet
- WFI Water for Injection · 5 mL injection
Ray Pharma: common questions
How many products does Ray Pharma have in Pakistan?
Ray Pharma has 58 registered medicine presentations in Pakistan, sold under 39 brands and covering 32 generic medicines.
What are the main brands of Ray Pharma?
By number of registered strengths and packs, its largest brands are Nixaray (Ciprofloxacin), Mikaray (Amikacin), Quezal (Quetiapine), Rayaz (Azithromycin) and Raylox (Levofloxacin). This is not a sales ranking.
Which therapy areas does Ray Pharma cover?
The most products are in Anti-infectives (32), Cardiovascular (9), CNS & mental health (7), Endocrine & metabolic (4) and Hematology & thrombosis (3).
Where can I see Ray Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.